All posts by: Michael Zand

About Michael Zand

Global Synthetic Biology Market Till 2024 Research Report | DecisionDatabases – Investor Opinion

Continue reading

2018-03-15 NEWS

Global Synthetic Biology Market Till 2024 Research Report | DecisionDatabases
Investor Opinion
Synthetic Biology Market Report added by DecisionDatabases.com offers industry size, share, growth, trends and forecast analysis upto 2024. Synthetic Biology Market Report also covers top key players, porter’s five forces analysis and market

and more »

Continue reading

2018-03-15 NEWS

Siliconrepublic.com

Irish biopharma company and UCD to use gene therapy for rare skin disorder
Siliconrepublic.com
With the aim of developing a treatment for a rare and debilitating skin disorder, an Irish biopharma company and UCD have signed a gene therapy licencing deal. Amryt, the Irish-listed biopharma company that focuses on rare and so-called ‘orphan
Amryt licenses gene therapy platform; refines its Phase III EASE study of AP101Proactive Investors UK
Amryt reports strong 2017 as revenues rise to almost €13mIrish Times
Irish company focused on bad cholesterol treatment sees revenue increase to €13mIndependent.ie

all 4 news articles »

Continue reading

2018-03-15 NEWS

WGN-TV

Immunotherapy giving hope to those with aggressive breast cancer
WGN-TV
But Moreno wasn’t ready to give up. She came to Lurie Comprehensive Cancer Center where they offered her the chance to be in a clinical trial testing two immunotherapy drugs already approved to treat lung and melanoma cancers. “We’re always happy when